Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Shanghai Stock Exchange 605016.SS

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Operating Income for the year ending December 31, 2023: USD 31.51 M

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Operating Income is USD 31.51 M for the year ending December 31, 2023, a 23.20% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 25.57 M, a 35.14% change year over year.
  • Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 18.92 M, a 11.53% change year over year.
  • Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 16.97 M, a 19.68% change year over year.
  • Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 14.18 M, a 25.59% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 605016.SS

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

Description

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. produces and sells functional sugar in China and internationally. It offers oligosaccharide products, such as oligofructose powder and liquid, isomalto oligosaccharide powder and liquid, xylo oligosaccharides, and galto oligosaccharides; dietary fiber products, including polydextrose and resistant dextrin; sugar alcohol products comprising crystalline maltitol and maltitol syrup; starch sugar products that include high fructose syrup, maltodextrin, and high maltose powder; special sugar products that consists of mono cake, bakery, and bread syrups; and fermentation products. The company was founded in 2005 and is based in Yucheng, China.

StockViz Staff

February 3, 2025

Any question? Send us an email